Extended Data Fig. 2: Incidence of treatment-related neutropenia following dalpiciclib plus fulvestrant treatment.

All treatment-emergent grade ≥ 3 neutropenia were judged as treatment related by the investigators.
All treatment-emergent grade ≥ 3 neutropenia were judged as treatment related by the investigators.